Latest News

China denies Trump's claims of negotiation, and eases some US tariffs

China exempted certain U.S. exports from its steep duties in a Friday sign that the trade conflict between the two world's largest economies may be easing. However, Beijing swiftly knocked back U.S. president Donald Trump's claim that negotiations were underway.

Business groups claim that China has allowed certain U.S. pharmaceuticals to enter without the 125% duty Beijing imposed on imports of the U.S. earlier this month as a response to Trump’s 145% tariffs.

A list of 131 categories of products that are allegedly being considered for exemptions is also circulating in some business and trade groups. The list includes chemicals, vaccines and jet engines. China has yet to make a public statement on the matter. Trump's administration in recent days has signaled that it is trying to de-escalate its confrontation with China. Trump himself also told TIME that there were talks taking place, and that Chinese president Xi Jinping called him.

He said, "I don’t think that it is a sign weakness on his part."

China denies that any discussions are taking place.

"China and the U.S. do NOT have any consultations or negotiations on #tariffs." The U.S. must stop confusing people," wrote the Chinese Embassy to Washington on social media. Trump announced tariffs for dozens of countries in addition to China. These tariffs will be suspended until July 9th.

This has sparked a scramble by U.S. trading partner to reach individual trade agreements with Washington before the deadline. It's a tall task, considering that previous trade deals took years to negotiate. Trump told reporters in the White House that an agreement with Japan was close. Analysts see this as a test case for other bilateral agreements, even though the talks may be difficult. Many expect Shigeru Shiba, the Prime Minister of Japan, and Donald Trump to announce an agreement when they meet in Canada at the G7 Summit in June.

Trump told TIME separately that he has made "200 deals", which he said would be finished within three to four week, but he refused to give specifics. He said that he would be happy if tariffs remained between 20% and 50% in a year. Trump has claimed that his thickets of trade barriers would revive U.S. Manufacturing Industries that have been eroded by global competition.

The majority of economists warn, however, that this would increase prices for U.S. consumer and raise the risk of recession.

U.S. stocks include

Down roughly 10%

Since Trump's return to office in January, indexes have lagged in other countries while the dollar has dropped at an unprecedented rate.

Stocks in Europe and Asia headed for a

Second straight week of gains

Investors were encouraged by signs that the U.S. was willing to end its trade war with China. Wall Street's major indexes increased slightly as investors sought clarity in the U.S. China trade dispute.

Trump has imposed tariffs on autos, steel, aluminum, and other imports in addition to country-specific duties. Trump has also proposed additional levies for the pharmaceutical and semiconductor industries. According to industry estimates, this could lead to a 12.9% increase in drug prices across the U.S.

The tariffs of Donald Trump dominated the discussions at this week's spring meetings of the International Monetary Fund (IMF) and World Bank, as finance ministers sought to meet with U.S. Treasury Sec. Scott Bessent.

Bessent characterized

Initial talks with South Korea

Seoul called Thursday's "good start" and "very successful." Next week, further discussions will take place.

Switzerland has also stated it

You will be satisfied

Bessent's initial meeting. The U.S. Trade Office said that it was "constantly engaging" with Japan and others, but Trump would decide whether or not they proceed.

Kristalina Georgeeva, the IMF's head, warned this week that they could lead to a rift between countries.

Severe slowdown

(Reporting by bureaus worldwide; Writing by Andy Sullivan; Editing by Chizu Nomiyama and Marguerita Choy) Reporting by Bureaus Worldwide; Writing by Andy Sullivan, Editing by Chizu nomiyama and Margueritachoy

(source: Reuters)